Date:
August 24, 2020
Issue #:
1605
Summary:
The FDA has approved cenobamate (Xcopri – SK Life
Science) for oral treatment of partial-onset (focal)
seizures in adults.
Science) for oral treatment of partial-onset (focal)
seizures in adults.
